Medical device maker cites regional disruptions as it abandons fiscal guidance while targeting annualized profitability gains.
Accuray withdrew its financial guidance for the current fiscal year, citing ongoing disruptions in the Middle East. The company did not specify the exact impact but emphasized the uncertainty affecting its operations in the region.
Prior to the withdrawal, Accuray had not provided a specific revenue or earnings forecast for the period. Analysts had expected modest growth, though no consensus estimate was widely published. The company last reported quarterly revenue of $102.3M in its fiscal Q2 2024.
Accuray reaffirmed its long-term target of $25M in annualized profitability improvement by fiscal 2027, aiming to offset near-term volatility with cost efficiencies and operational adjustments.